Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Hepatic Metastases of Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03031444
What this trial is testing

Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis

Who this might be right for
Colorectal Cancer Stage IVMetastasis
Peking University Cancer Hospital & Institute 135
Not applicableStudy completedNCT06550700
What this trial is testing

The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open Surgery

Who this might be right for
Resectable Simultaneous Colorectal Cancer Liver Metastasis
Changhai Hospital 266
Early research (Phase 1)Study completedNCT02754856
What this trial is testing

Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Metastatic Carcinoma in the LiverResectable MassStage IV Colorectal Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01348412
What this trial is testing

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Who this might be right for
Colorectal CancerLiver Metastases
Centre Georges Francois Leclerc 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612007
What this trial is testing

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+1 more
Mayo Clinic 80
Not applicableUnknownNCT02355353
What this trial is testing

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Not applicableActive Not RecruitingNCT04161092
What this trial is testing

The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Liver Metastases
Vastra Gotaland Region 45
Large-scale testing (Phase 3)Looking for participantsNCT05797077
What this trial is testing

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

Who this might be right for
Colorectal CancerLiver MetastasesCirculating Tumor Cell+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 346
Not applicableStudy completedNCT06936098
What this trial is testing

Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer Subtypes

Who this might be right for
Colorectal Liver Metastasis (CRLM)Histopathological Growth Patterns (HGPs)Artificial Intelligence (AI) in Diagnosis+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 431
Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Large-scale testing (Phase 3)UnknownNCT00482222
What this trial is testing

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Southampton 340
Not applicableNot Yet RecruitingNCT06504901
What this trial is testing

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)UnknownNCT01802645
What this trial is testing

Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
Technische Universität Dresden 91
Not applicableUnknownNCT02886104
What this trial is testing

Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis

Who this might be right for
Secondary Malignant Neoplasm of Liver
Sixth Affiliated Hospital, Sun Yat-sen University 548
Large-scale testing (Phase 3)UnknownNCT02912052
What this trial is testing

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

Who this might be right for
Colon Cancer
The First Affiliated Hospital with Nanjing Medical University 240
Large-scale testing (Phase 3)Active Not RecruitingNCT03428477
What this trial is testing

EPA for Metastasis Trial 2

Who this might be right for
Liver MetastasisColon Cancer
Mark A Hull, PhD FRCP 418
Testing effectiveness (Phase 2)UnknownNCT03711240
What this trial is testing

The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
National Cheng-Kung University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01632722
What this trial is testing

Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets

Who this might be right for
Colorectal CancerLiver Metastasis
Yonsei University 79
Not applicableStudy completedNCT01343901
What this trial is testing

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 210
Testing effectiveness (Phase 2)Study completedNCT02086656
What this trial is testing

PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

Who this might be right for
Colorectal Cancer Liver Metastases
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 46
Next Page